It was worth noting that all of these changes were obviously reversed by EPD treatment, which provided evidence that TLR7/8–MyD88–NF-κB signaling was involved in the therapeutic action of EPD on psoriasis. This evidence concerns the gene NFKB1 and psoriasis.